(Reuters) - Pfizer Inc, which in May abandoned its $118 billion bid to buy AstraZeneca Plc, on Tuesday left investors guessing whether it would renew its pursuit of its British rival, but said it was considering other deals. [Category: healthNews] http://feeds.reuters.com/~r/reuters/healthNews/~3/LEmMAFtuHYM/story01.htm
Read More
No comments:
Post a Comment